This grant supports exploratory and developmental research projects aimed at cancer control by modifying behavior, improving screening, understanding etiologic factors, and developing innovative techniques or models. It encourages novel scientific ideas with potential major impact across epidemiologic, biomedical, behavioral, health care delivery, or clinical cancer research domains. Clinical trials are optional under this R21 grant mechanism.
Eligible applicants include a wide range of organizations such as small businesses, institutions of higher education, nonprofits, government entities, tribal organizations, and foreign entities. Specific eligibility details are extensive and include various federally recognized and non-recognized gr
